BD細胞凋亡試劑盒（FITC標記）FITC Annexin V Apoptosis Detectio
BD細胞凋亡試劑盒（FITC標記）FITC Annexin V Apoptosis Detection Kit I
現貨*
Technical Data Sheet
FITC Annexin V Apoptosis Detection Kit I
Product Information
Material Number: 556547
Component: 51-66121E
Description: 10X Annexin V Binding Buffer
Size: 50 ml （1 ea）
Storage Buffer: Aqueous buffered solution containing no preservative.
Component: 51-65874X
Description: FITC Annexin V
Size: 0.5 ml （1 ea）
Vol. per Test: 5 μl
Storage Buffer: Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Component: 51-66211E
Description: Propidium Iodide Staining Solution
Size: 2.0 ml （1 ea）
Vol. per Test: 5 μl
Storage Buffer: Aqueous buffered solution containing no preservative.
Description
Apoptosis is a normal physiologic process which occurs during embryonic development as well as in maintenence of tissue homeostasis. The
apoptotic program is characterized by certain morphologic features, including loss of plasma membrane asymmetry and attachment,
condensation of the cytoplasm and nucleus, and internucleosomal cleavage of DNA. Loss of plasma membrane is one of the earliest features.
In apoptotic cells, the membrane phospholipid phosphatidylserine （PS） is translocated from the inner to the outer leaflet of the plasma
membrane, thereby exposing PS to the external cellular environment. Annexin V is a 35-36 kDa Ca2+ dependent phospholipid-binding
protein that has a high affinity for PS, and binds to cells with exposed PS. Annexin V may be conjugated to fluorochromes including FITC.
This format retains its high affinity for PS and thus serves as a sensitive probe for flow cytometric analysis of cells that are undergoing
apoptosis. Since externalization of PS occurs in the earlier stages of apoptosis, FITC Annexin V staining can identify apoptosis at an earlier
stage than assays based on nuclear changes such as DNA fragmentation.
FITC Annexin V staining precedes the loss of membrane integrity which accompanies the latest stages of cell death resulting from either
apoptotic or necrotic processes. Therefore, staining with FITC Annexin V is typically used in conjunction with a vital dye such as propidium
iodide （PI） or 7-Amino-Actinomycin （7-AAD） to allow the investigator to identify early apoptotic cells （PI negative, FITC Annexin V
positive）. Viable cells with intact membranes exclude PI, wheras the membranes of dead and damaged cells are permeable to PI. For example,
cells that are considered viable are FITC Annexin V and PI negative; cells that are in early apoptosis are FITC Annexin V positive and PI
negative; and cells that are in late apoptosis or already dead are are both FITC Annexin V and PI positive. This assay does not distinguish
between cells that have undergone apoptotic death versus those that have died as a result of a necrotic pathway because in either case, the dead
cells will stain with both FITC Annexin V and PI. However, when apoptosis is measured over time, cells can be often tracked from FITC
Annexin V and PI negative （viable, or no measurable apoptosis）, to FITC Annexin V positive and PI negative （early apoptosis, membrane
integrity is present） and finally to FITC Annexin V and PI positive （end stage apoptosis and death）. The movement of cells through these three
stages suggests apoptosis. In contrast, a single observation indicating that cells are both FITC Annexin V and PI positive, in of itself, reveals
less information about the process by which the cells underwent their demise.
Preparation and Storage
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
556547 Rev. 5 Page 1 of 3
Flow Cytometric Analysis of FITC Annexin V staining. Jurkat cells
（Human T-cell leukemia; ATCC TIB-152） were left untreated （top
panels） or treated for 4 hours with 12 μM campotothecin （bottom
panels）. Cells were incubated with FITC Annexin V in a buffer
containing propidium iodide （PI） and analyzed by flow cytometry.
Untreated cells were primarily FITC Annexin V and PI negative,
indicating that they were viable and not undergoing apoptosis. After a
4 hour treatment （bottom panels）, there were primarily two
populations of cells: Cells that were viable and not undergoing
apoptosis （FITC Annexin V and PI negative） and cells undergoing
apoptosis （FITC Annexin V positive and PI negative）. A minor
population of cells were observed to be FITC Annexin V and PI
positive, indicating that they were in end stage apoptosis or already
dead.
Application Notes
Application
Flow cytometry Routinely Tested
Recommended Assay Procedure:
FITC Annexin V is a sensitive probe for identifying apoptotic cells, binding to negatively charged phospholipid surfaces （Kd of ~5 x 10^-2） with
a higher affinity for phosphatidylserine （PS） than most other phospholipids. FITC Annexin V binding is calcium dependent and defined calcium
and salt concentrations are required for optimal staining as described in the FITC Annexin V Staining Protocol. Investigators should note that
FITC Annexin V flow cytometric analysis on adherent cell types （e.g HeLa, NIH 3T3, etc.） is not routinely tested as specific membrane
damage may occur during cell detachment or harvesting. Methods for utilizing Annexin V for flow cytometry on adherent cell types,
however, have been previously reported （Casiola-Rosen et al. and van Engelend et al.）.
INDUCTION OF APOPTOSIS BY CAMPTOTHECIN
The following protocol is provided as an illustration on how FITC Annexin V may be used on a cell line （Jurkat）.
BD細胞凋亡試劑盒（FITC標記）FITC Annexin V Apoptosis Detection Kit I
Materials
1. Prepare Camptothecin stock solution （Sigma-Aldrich Cat. No. C-9911）: 1 mM in DMSO.
2. Jurkat T cells （ATCC TIB-152）.
Procedure
1. Add Camptothecin （final conc. 4-6 μM） to 1 x 10^6 Jurkat cells.
2. Incubate the cells for 4-6 hr at 37°C.
3. Proceed with the FITC Annexin V Staining Protocol to measure apoptosis.
FITC ANNEXIN V STAINING PROTOCOL
FITC Annexin V is used to quantitatively determine the percentage of cells within a population that are actively undergoing apoptosis. It relies on
the property of cells to lose membrane asymmetry in the early phases of apoptosis. In apoptotic cells, the membrane phospholipid
phosphatidylserine （PS） is translocated from the inner leaflet of the plasma membrane to the outer leaflet, thereby exposing PS to the external
environment. Annexin V is a calcium-dependent phospholipid-binding protein that has a high affinity for PS, and is useful for identifying
apoptotic cells with exposed PS. Propidium Iodide （PI） is a standard flow cytometric viability probe and is used to distinguish viable from
nonviable cells. Viable cells with intact membranes exclude PI, whereas the membranes of dead and damaged cells are permeable to PI. Cells that
stain positive for FITC Annexin V and negative for PI are undergoing apoptosis. Cells that stain positive for both FITC Annexin V and PI are
either in the end stage of apoptosis, are undergoing necrosis, or are already dead. Cells that stain negative for both FITC Annexin V and PI are
alive and not undergoing measurable apoptosis.
556547 Rev. 5 Page 2 of 3
Reagents
1. FITC Annexin V （component no. 51-65874X）: Use 5 μl per test.
2. Propidium Iodide （PI） （component no. 51-66211E） is a convenient, ready-to-use nucleic acid dye. Use 5 μl per test.
3. 10X Annexin V Binding Buffer （component no. 51-66121E）: 0.1 M Hepes/NaOH （pH 7.4）, 1.4 M NaCl, 25 mM CaCl2. For a 1X working
solution, dilute 1 part of the 10X Annexin V Binding Buffer to 9 parts of distilled water.
Staining
1. Wash cells twice with cold PBS and then resuspend cells in 1X Binding Buffer at a concentration of 1 x 10^6 cells/ml.
2. Transfer 100 μl of the solution （1 x 10^5 cells） to a 5 ml culture tube.
3. Add 5 μl of FITC Annexin V and 5 μl PI.
4. Gently vortex the cells and incubate for 15 min at RT （25°C） in the dark.
5. Add 400 μl of 1X Binding Buffer to each tube. Analyze by flow cytometry within 1 hr.
SUGGESTED CONTROLS FOR SETTING UP FLOW CYTOMETRY
The following controls are used to set up compensation and quadrants:
1. Unstained cells.
2. Cells stained with FITC Annexin V （no PI）.
3. Cells stained with PI （no FITC Annexin V）.
Other Staining Controls:
A cell line that can be easily induced to undergo apoptosis should be used to obtain positive control staining with FITC Annexin V and/or FITC
Annexin V and PI. It is important to note that the basal level of apoptosis and necrosis varies considerably within a population. Thus, even in the
absence of induced apoptosis, most cell populations will contain a minor percentage of cells that are positive for apoptosis （FITC Annexin V
positive, PI negative or FITC Annexin V positive, PI positive）.
The untreated population is used to define the basal level of apoptotic and dead cells. The percentage of cells that have been induced to undergo
apoptosis is then determined by subtracting the percentage of apoptotic cells in the untreated population from percentage of apoptotic cells in the
treated population. Since cell death is the eventual outcome of cells undergoing apoptosis, cells in the late stages of apoptosis will have a damaged
membrane and stain positive for PI as well as for FITC Annexin V. Thus the assay does not distinguish between cells that have already undergone
an apoptotic cell death and those that have died as a result of necrotic pathway, because in either case the dead cells will stain with both FITC
Annexin V and PI.
Product Notices
1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before
discarding to avoid accumulation of potentially explosive deposits in plumbing.
3.
4. Please refer to www.bdbiosciences.com/pharmingen/protocols for technical protocols.
References
Andree HA, Reuingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant alpha （VAC alpha） to planar
phospholipid bilayers. J Biol Chem. 1990; 265（9）:4923-4928. （Biology）
Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events
and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1996; 93（4）:1624-1629. （Biology）
Homburg CH, de Haas M, von dem Borne AE, Verhoeven AJ, Reuingsperger CP, Roos D. Human neutrophils lose their surface Fc gamma RIII and acquire
Annexin V binding sites during apoptosis in vitro. Blood. 1995; 85（2）:532-540. （Biology）
Koopman G, Reuingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on
B cells undergoing apoptosis. Blood. 1994; 84（5）:1415-1420. （Biology）
Martin SJ, Reuingsperger CP, McGahon AJ, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of
the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995; 182（5）:1545-1556. （Biology）
O'Brien MC, Bolton WE. Comparison of cell viability probes compatible with fixation and permeabilization for combined surface and intracellular staining in flow
cytometry. Cytometry. 1995; 19（3）:243-255. （Biology）
Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins.
Biochim Biophys Acta. 1994; 1197（1）:63-93. （Biology）
Schmid I, Krall WJ, Uittenbogaart CH, Braun J, Giorgi JV. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence
in single laser flow cytometry. Cytometry. 1992; 13（2）:204-208. （Biology）
van Engeland M, Ramaekers FC, Schutte B, Reuingsperger CP. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent
cells in culture. Cytometry. 1996; 24（2）:131-139. （Biology）
Vermes I, Haanen C, Steffens-Nakken H, Reuingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early
apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995; 184（1）:39-51. （Biology）
n Kit I詳細產品信息可和選購
© 2019 上海力敏實業有限公司 版權所有 備案號：滬ICP備12020044號-1 技術支持：環保在線 GoogleSitemap 總訪問量：983001 管理登陸
